Skip to NavigationSkip to content

Pharmafile - Business Services News

Mylan’s EpiPen scandal continues to deepen as CMS contends that they underpaid rebates to state Medicaid programs.
The company is selling the UK and Ireland branches of the business to India’s Intas Pharmaceuticals.
Alnylam Pharmaceuticals suffered a huge blow to its market value after a catastrophic failure in a Phase III trial.
Firm is to shut down research operations in Switzerland and China in an effort to cut costs and centralise its drug discovery programmes.
Merck’s Keytruda (penmbrolizumab), used to treat advanced non-small-cell lung cancer has received a knockback from NICE.
UK pharma firm agrees payment to the US Securities and Exchange Commission to settle allegations of bribing foreign officials with gifts recorded as...
Advances in Oncology, our supplement featuring all the latest in tumour research and treatment, is available to read online now!
It's been a busy week in news with breaking scandals and new drug developments hitting the headlines. Check out the most read stories on Pharmafile....
AbbVie opened its first manufacturing factory in Asia with a 120,000 square meter space comprising the small molecule active pharmaceutical...
Read all about Mylan's EpiPen price hike scandal, Bayer's historic acquisition of agricultural firm Monsanto, and special features examining the...
Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches